Opal has a number of generic developments, which include the establishment of its own specifically targeted niche hospital injectable and other similar preparations.
The founders have recognised that the marketplace for pharmaceuticals has changed and is changing rapidly.
Their industry experience had convinced them that there was a major opportunity to develop unique dosage and packaging forms, incorporating novel delivery technology providing flexibility and ease-of-use for hospital physicians, pharmacists and patients for many effective off-patent drugs whose pharmacology and safety is well documented.
Opal was and remains focused upon the development and supply of customised, high value injectable drugs for hospital and specialist applications and in particular upon antibiotic, anti-fungal, anti-infective and cardiovascular products.